Efavirenz 200mg tabs/PAC-30

NOTE: This material number provides a description of a standard material available in this material group, but is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Efavirenz 200mg film coated tablets, pack of 30

Technical Specifications:
Each film coated tablet contains Efavirenz 200mg

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
2 Years (24 months)

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in adults and children over 3 years of age in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Storage:
Do not store above 30ºC (86ºF), do not freeze.
Store in tightly closed original container
Keep out of reach and sight of children

Dispensing instructions:
Dispense in original container. Do not repack
Advise patient to take the medicine on empty stomach and at bedtime, especially in the first 2-4 weeks to reduce CNS effects.
Note: The dose of Efavirenz oral solution in mg of Efavirenz is not the same as for Efavirenz capsules and tablets.

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items